Institutional Biosafety Committee (IBC)
The UTSA Institutional Biosafety Committee is a registered committee with the National Institutes of Health. This Committee reviews research protocols that involve potentially biohazardous materials and agents, recombinant and synthetic nucleic acids and the use of tissue isolated from vertebrates. The purpose of these reviews is to ensure that all activities involving these materials, and the facilities used to conduct such work, are in compliance with all applicable external regulations and University policies. The IBC is composed of UTSA research faculty, representatives from the UTSA Office of Research Integrity and community members outside the University. The committee meets the first Wednesday of each month.
IBC Information
Meetings for Fiscal Year 24 are scheduled for the FIRST WEDNESDAY of each month at 9:00 AM (January excluded)
It is essential to submit protocols by the deadline in order to give all members of the committee adequate time to do thorough evaluations of each protocol.
Submit completed applications electronically on BioRaft. For assistance please contact the IBC office at (210) 458-5807.
For details of meeting locations, please contact: mohammadsr.khan@utsa.edu.
| Forms |
|---|
| American Type Culture Collection (ATCC) |
| CDC Select Agent Program |
- Submit completed UTSA IBC protocol application form(s) electronically on BioRaft
- Application is placed on Agenda for next meeting and distributed to IBC for Full Committee Review.
- Chair and Biological Safety Officer pre-review application and present for discussion by committee at regular meeting on 1st Wednesday of each month.
- Possible outcomes of IBC review are reflected in the Score assigned to the application:
- Approved (PI will get the approval email from BioRaft, PI will get the written approved letter upon request)
- Tabled Pending Modifications and Re-review by Chairman
- Tabled Pending Modifications and Re-review by IBC at next convened meeting
- Declined (Disapproved)
- Decision Notification. With a Score of 2, 3 or 4, the protocol application is returned to PI with written notification of the concerns of the committee through BioRaft.
- Time required for subsequent actions/approval is heavily dependent upon the actions taken by the PI. A Score of “2” means that the revised application needs only to be re-reviewed by the Chairman (and any other IBC member who either specifically requests to be involved in the re-review or is asked by the Chairman to participate). That re-review can be done as soon the PI revises the application in light of the Decision Notification. If an application receives a Score of “3”, there are more substantive concerns with it, and the committee has voted to have the revision re-reviewed by the Full Committee at the meeting for which the submission of the revision meets the submission deadline. Clearly, the PI has the larger role in determining how long it takes to get his/her application approved.
- Contact the IBC office ibc@utsa.edu, (210) 458-5807 for further information.
Members
FY 24
- Dr. Jose Lopez-Ribot, Chair
- Dr. Janakiram Seshu, Vice-Chair
- Dr. Astrid Cardona
- Dr. Jieh Juen Yu
- Dr. Karl Klose
- Dr. Jurgen Engelberth
- Dr. Marcel Perret-Gentil
- Dr. Soo Chan Lee
- Dr. Hamid Badali
- Dr. Ana Vallor (non-affiliate)
- Dr. Shannon Hall-Ursone (non-affiliate)
- Ms. Jolyn Dominguez
- Mr. Mohammad Siddiqur Rahman Khan
- Mr. Richard Garza
- Ms. Yolanda Acosta
- Mr. Anthony Vallejo